ClinicalTrials.Veeva

Menu

Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression

U

University of Southampton

Status

Enrolling

Conditions

Colorectal Cancer

Treatments

Other: biomarker study

Study type

Observational

Funder types

Other

Identifiers

NCT03309722
UKCRNID6067

Details and patient eligibility

About

Molecular pathology of Colorectal Cancer: Investigating the role of novel molecular profiles, microRNA's and their targets in Colorectal Cancer progression

Full description

Single centre observational cohort study Prospectively recruited patients biomarker evaluation and identification of novel biomarkers

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • colorectal cancer

Exclusion criteria

  • hereditary CRC; tumours with extensive necrosis

Trial design

1,000 participants in 2 patient groups

early stage
Treatment:
Other: biomarker study
advanced
Treatment:
Other: biomarker study

Trial contacts and locations

1

Loading...

Central trial contact

Alex Mirnezami, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems